Neboglamine (hydrochloride)
Neboglamine (CR-2249, XY-2401) hydrochloride is an orally active NMDA receptor glycine site positive modulator that can be used in schizophrenia research[1].
Product Specifications
CAS Number
[2759182-59-5]
Product Name Alternative
CR-2249 (hydrochloride) ; XY-2401 (hydrochloride)
UNSPSC
12352211
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/neboglamine-hydrochloride.html
Purity
97.02
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC(CC[C@H](N)C(NC1CCC(C)(CC1)C)=O)=O.Cl
Molecular Formula
C13H25ClN2O3
Molecular Weight
292.80
References & Citations
[1]Riccardo Chiusaroli, et al. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat. Pharmacol Res. 2010 May;61 (5) :430-6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NMDA Receptor
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
CD28-3909HAF647 20 μg- 50 μg- 100 μg
Recombinant Human CD28 Protein, Fc-tagged, Alexa Fluor 647 conjugated
Sign In for Pricing
View Details TL705375V 500 µL Each
Naalad2 Rat shRNA Lentiviral Particle (Locus ID 300384)
Sign In for Pricing
View Details 
